Man Group
SRNE

Man Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Man Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-182,000
Closed -$424K – 2511
2022
Q1 		$424K Buy
+182,000
New +$568K ﹤0.01% 1636
2021
Q2 		– Sell
-159,775
Closed -$1.32M – 2142
2021
Q1 		$1.32M Buy
+159,775
New +$1.69M 0.01% 1221
2018
Q4 		– Sell
-253,990
Closed -$1.12M – 2176
2018
Q3 		$1.12M Buy
+253,990
New +$1.41M ﹤0.01% 1628
2018
Q2 		– Sell
-1,342,616
Closed -$6.91M – 2272
2018
Q1 		$6.91M Buy
+1,342,616
New +$9.55M 0.03% 672

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return